Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference16 articles.
1. K.-O. Haustein, C. Pachaly, R. Megges, and F. Franke. Investigation into species-specific deacylation of penta-acetyl-gitoxin.Eur. J. Clin. Pharmacol. 14:425–430 (1978).
2. H. Fiehring, A. Sundermann, and J. Knappe. Penta-acetyl-gitoxin—Ein neues Herzglykosid.Dtsch. Gesundh.-Wesen 18:1334–1338 (1963).
3. K.-O. Haustein, R. G. Alken, H.-J. Lach, U. Becker, and N. Rietbrock. On the pharmacokinetics of pengitoxin and its cardioactive derivative 16-acetyl-gitoxin.Eur. J. Clin. Pharmacol. 25:369–373 (1983).
4. E. Weiler and H.-J. Lach. Direct radioimmunoassay for the determination of 16-acetyl-gitoxin in serum.Clin. Chim. Acta 104:337–343 (1980).
5. K.-O. Haustein, C. Pachaly, and D. Murawski. Pharmacokinetic investigations with3H-penta-acetyl-gitoxin in volunteers and patients with respect to the occurrence of drug latentiation.Int. J. Clin. Pharmacol. 16:285–289 (1978).